Physician profile
Melanie Pistentis
NPI 1932487808
$2,217.70
in general payments reported to CMS, 2019-2025
18 companies · $5.56 in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $604 · 2022: $484 · 2023: $787 · 2024: $338 · 2025: $5.56.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,125 · Education: $5.56.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,124.61 |
| Education | $5.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $436.49 | 2023-2024 | Orgovyx, Gemtesa |
| Janssen Biotech, INC. | $334.78 | 2021-2024 | Erleada |
| Astellas Pharma US INC | $332.51 | 2021-2024 | Xtandi, Myrbetriq |
| Myovant Sciences INC. | $269.72 | 2021-2022 | |
| Pfizer INC. | $173.54 | 2021-2023 | |
| Myriad Genetic Laboratories, INC. | $109.81 | 2022-2023 | Prolaris |
| Dendreon Pharmaceuticals LLC | $108.19 | 2021-2024 | Provenge |
| Tolmar, INC. | $96.65 | 2023-2024 | |
| Tolmar Pharmaceuticals, INC. | $81.57 | 2021-2022 | |
| Urovant Sciences INC | $75.44 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $51.51 | 2021-2023 | |
| Accord Healthcare, INC. | $41.71 | 2022-2023 | |
| Cumberland Pharmaceuticals, INC. | $27.41 | 2021 | |
| Progenics Pharmaceuticals, INC. | $22.11 | 2022 | |
| Glaxosmithkline, LLC. | $18.66 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Blue Earth Diagnostics | $18.50 | 2021 | |
| Abbvie INC. | $13.54 | 2023 | |
| Travere Therapeutics, INC. | $5.56 | 2025 | Thiola |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melanie Pistentis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.